Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study-Reference-Cited by-同舟云学术

Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study

Published:2023-12 Issue: Volume:15 Page:90-99
ISSN:2667-2421
Container-title:IBRO Neuroscience Reports
language:en
Short-container-title:IBRO Neuroscience Reports

Author:

Raghavan Kadalraja,Dedeepiya Vidyasagar Devaprasad,Srinivasan Subramaniam,Pushkala Subramanian,Bharatidasan Sudhakar S.,Ikewaki Nobunao,Iwasaki Masaru^ORCID,Senthilkumar Rajappa,Preethy Senthilkumar,Abraham Samuel J.K.^ORCID

Publisher

Elsevier BV

Subject

General Neuroscience

Reference42 articles.

1. M.R.C. Muscle Scale. 〈https://mrc.ukri.org/research/facilities-and-resources-for-researchers/mrc-scales/mrc-muscle-scale/〉 (Accessed: December 13, 2021).

2. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence;Augier;J. Neurol. Sci.,1992

3. Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients;Awano;Clin. Chim. Acta,2018

4. Microbiome in multiple sclerosis; where are we, what we know and do not know;Boziki;Brain Sci.,2020

5. Modifying muscular dystrophy through transforming growth factor-β;Ceco;FEBS J.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan;Scientific Reports;2023-10-09

2. Reduction in myocardial fibrosis in MDX mice on oral consumption ofAureobasidium Pullulansproduced Neu REFIX Beta-glucans; holds potential as an adjuvant in managing post-transplantation organ fibrosis;2023-09-28

3. Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial;2023-09-08

4. Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach;Journal of Smooth Muscle Research;2023